Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

henagliflozin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract 1. Henagliflozin is a novel sodium-glucose transporter 2 inhibitor and presents a complementary therapy to metformin for… Expand
2015
2015
Background and ObjectiveHenagliflozin, a selective inhibitor of the renal sodium glucose cotransporter-2, was developed for type… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2